9 oct 2018
CPhI Worldwide 2018
Valpharma International SpA

Valpharma International SpA

Exhibitor at CPhI Worldwide 2018 stand 14.0C21, Finished Dosage Formulations

About us

Since more than 40 years, VALPHARMA has been specialized in the development and contract manufacture of modified release products in capsules (hard-soft) and tablets, with own technology, supplying them to pharmaceutical companies worldwide. Its own R&D Department develops annually many new products in modified release form with own patents, changing posology from three or more daily dosings into once-twice daily dosing, optimizing pharmaceutical effects and reducing side-effects. Authorized by the Italian, Brazilian, Iranian, Ivory Coast, Japanese, Turkish, Taiwanese and United Arab Emirates Health Authorities to manufacture pharmaceutical, nutraceutical, investigational medicinal products, controlled drugs and high potent drugs (sexual hormones). VALPHARMA has a close collaboration, open and transparent dialogue with pharmaceutical industries all over the world, including the most important multinationals, basing on signed agreements, with a manufacture of 1,7 billion doses/year and 300 products developed by our laboratories.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Contract Manufacturing |Custom Manufacturing (general category) |Formulation development More

Products featured at CPhI Worldwide 2018

Valpharma International SpA

Event information

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain Visit us at stand 14.0C21